Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. May-Jun 2014;54(3):251-7.
doi: 10.1331/JAPhA.2014.13097.

Discussions Between Medical Providers and Children/Caregivers About the Benefits of Asthma-Control Medications

Discussions Between Medical Providers and Children/Caregivers About the Benefits of Asthma-Control Medications

Chris Gillette et al. J Am Pharm Assoc (2003). .

Abstract

Objectives: To describe the content of discussions between general pediatric providers and children and their caregivers about the benefits of asthma-control medication; describe the extent to which these discussions occur; and examine factors that are associated with medication benefit discussions.

Design: Cross-sectional secondary analysis of audiotaped medical visits.

Setting: Five primary care pediatric clinics in North Carolina.

Participants: 35 pediatric providers and 248 children with persistent asthma and their caregivers.

Main outcome measures: Presence of discussion about benefits associated with asthma-control medications.

Results: Providers discussed benefits associated with asthma-control medications during 56% of medical visits. Benefits were more likely to be discussed when the child was younger and when medication adherence was discussed during the visit. When providers discussed benefits of asthma-control medications, they were most likely to ask questions and make statements regarding symptom control/prevention.

Conclusion: General pediatric medical providers often do not discuss the benefits of asthma-control medications. Pharmacists could fill this information gap by counseling both children and their caregivers about benefits that a child with asthma can expect as a result of treatment.

Similar articles

See all similar articles

Publication types

Feedback